Synthesis, molecular modeling, anti-cancer and COX-1/2 inhibitory activities of novel thiazolidinones containing benzothiazole core
DOI:
https://doi.org/10.3329/bjp.v19i1.70297Keywords:
Anti-cancer, Benzothiazole, Cox-1 inhibitor, Cox-2 inhibitor, Molecular docking, Synthesis, ThiazolidinoneAbstract
In this study, new 1,3-thiazolidin-4-one derivatives containing arylmethylene groups in the 5-position were obtained from 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine (riluzole). Synthesized compounds were characterized by spectral data and elemental analysis. In vitro, cytotoxic activities of the synthesized molecules were evaluated against the human lung cancer (A549) and human prostate cancer (PC-3) cell lines. Compounds were also tested on mouse embryonic fibroblast cells (NIH/3T3) to determine selectivity. Ten target compounds 3-12 were also screened for their COX-1 and COX-2 inhibitory activities. Of these compounds, 4 showed the highest COX-2 inhibition at 10 μM. Molecular docking calculations were performed to understand the binding interactions of compounds with COX-1 and COX-2 proteins. In silico studies of the tested compounds represented important binding modes that may be responsible for their anti-cancer activity via selective inhibition of the COX-2 enzyme. ADMET predictions were conducted to assess the drug-like properties of the novel compounds.
Downloads
75
103 Supplementary Data
50
References
Abdellatif KRA, Abdelall EKA, Abdelgawad MA, Abdelhakeem MM, Omar HA. Design and synthesis of certain novel arylidene thiazolidinone derivatives as anti-cancer agents. Der Pharma Chem. 2015; 7: 149-61.
Abdellatif KRA, Abdelgawad MA, Elshemy HAH, Alsayed SSR. Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selec-tivity, anti-inflammatory activity and gastric safety profile. Bioorg Chem. 2016; 64: 1-12.
Akhtar T, Hameed S, Al-Masoudı NA, Loddo R, La Colla P. In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives. Acta Pharm. 2008; 58: 135-49.
Apostolidis I, Liaras K, Geronikaki A, Hadjipavlou-Litina D, Gavalas A, Soković M, Glamočlija J, Ćirić A. Synthesis and biological evaluation of some 5-arylidene-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-ones as dual anti-inflammatory/antimicrobial agents. Bioorg Med Chem. 2013; 21: 532-39.
Bahuguna A, Khan I, Bajpai VK, Kang SC. MTT assay to evaluate the cytotoxic potential of a drug. Bangladesh J Pharmacol. 2017; 12: 115-18.
Bülbül B, Ding K, Zhan CG, Çiftçi G, Yelekçi K, Gürboğa M, Özakpınar ÖB, Aydemir E, Baybağ D, Şahin F, Kulabaş N, Helvacıoğlu S, Charehsaz M, Tatar E, Özbey S, Küçükgüzel İ. Novel 1,2,4-triazoles derived from ibuprofen: Synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity. Mol Divers. 2022: (early access).
Çakir G, Kücükgüzel I, Guhamazumder R, Tatar E, Manvar D, Basu A, Patel BA, Zia J, Talele TT, Kaushik-Basu N. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase. Arch Pharm (Weinheim). 2015; 348: 10-22.
Catalano A, Carocci A, Defrenza I, Muraglia M, Carrieri A, Van Bambeke F, Rosato A, Corbo F, Franchini C. 2-Amino-benzothiazole derivatives: Search for new antifungal agents. Eur J Med Chem. 2013; 64: 357-64.
Eleftheriou P, Geronikaki A, Hadjipavlou-Litina D, Vicini P, Filz O, Filimonov D, Poroikov V, Chaudhaery SS, Roy KK, Saxena AK. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. Eur J Med Chem. 2012; 47: 111-24.
Geronikaki A, Eleftheriou P, Vicini P, Alam I, Dixit A, Saxena AK. 2-Thiazolylimino/Heteroarylimino-5-arylidene-4-thia-zolidinones as new agents with SHP-2 inhibitory action. J Med Chem. 2008; 51: 1.
Gupta K, Selinsky BS, Kaub CJ, Katz AK, Loll PJ. The 2.0 Å resolution crystal structure of prostaglandin H2 synthase-1: Structural insights into an unusual peroxidase. J Mol Biol. 2004; 335: 503-18.
Haroun M, Tratrat C, Petrou A, Geronikaki A, Ivanov M, Ciric A, Sokovic M. 2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies. Bioorg Med Chem Lett. 2021; 32: 127718.
Havrylyuk D, Mosula L, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R. Synthesis and anti-cancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur J Med Chem. 2010; 45: 5012-21.
Jung ME, Ku JM, Du L, Hu H, Gatti RA. Synthesis and evalua-tion of compounds that induce readthrough of premature termination codons. Bioorg Med Chem Lett 2011; 21: 5842-48.
Küçükgüzel I, Satılmış G, Gurukumar KR, Basu A, Tatar E, Nichols DB, Talele TT, Kaushik-Basu N. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase. Eur J Med Chem. 2013; 69: 931-41.
Kulabaş N, Özakpinar ÖB, Özsavcı D, Leyssen P, Neyts J, Küçükgüzel İ. Synthesis, characterization and biological evaluation of thioureas, acylthioureas and 4-thiazolidinones as anti-cancer and antiviral agents. Marmara Pharm J. 2017; 21: 371-84.
Kulabaş N, Set İ, Aktay G, Gürsoy Ş, Danış Ö, Ogan A, Sağ Erdem S, Erzincan P, Helvacıoğlu S, Hamitoğlu M, Küçük-güzel İ. Identification of some novel amide conjugates as potent and gastric sparing anti-inflammatory agents: In vitro, in vivo, in silico studies and drug safety evaluation. J Mol Struct. 2023; 1285.
Kulabaş N, Türe A, Bozdeveci A, Krishna VS, Alpay Karaoğlu Ş, Sriram D, Küçükgüzel İ. Novel fluoroquinolones containing 2-arylamino-2-oxoethyl fragment: Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies. J Heterocycl Chem. 2022; 59: 909–26.
Kumar AS, Kudva J, Bharath BR, Ananda K, Sadashiva R, Madan Kumar S, Revanasiddappa BC, Kumar V, Rekha PD, Naral D. Synthesis, structural, biological and in silico studies of new 5-arylidene-4-thiazolidinone derivatives as possible anti-cancer, antimicrobial and antitubercular agents. New J Chem. 2019; 43: 1597–610.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997; 23: 3-25.
Liu DC, Zhang HJ, Jin CM, Quan ZS. Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticonvulsant agents. Molecules 2016; 21: 164.
Manvar D, Küçükgüzel I, Erensoy G, Tatar E, Deryabaşoʇullari G, Reddy H, Talele TT, Cevik O, Kaushik-Basu N. Discovery of conjugated thiazolidinone-thiadiazole scaffold as anti-dengue virus polymerase inhibitors. Biochem Biophys Res Commun. 2016; 469: 743-47.
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. Software news and updates gabedit: A graphical user interface for computational chemistry softwares. J Comput Chem. 2009; 30: 174-82.
Mushtaque M, Avecilla F, Azam A. Synthesis, characterization and structure optimization of a series of thiazolidinone derivatives as Entamoeba histolytica inhibitors. Eur J Med Chem. 2012; 55: 439-48.
Nowaczyk A, Kowiel M, Gzella A, Fijałkowski Ł, Horishny V, Lesyk R. Conformational space and vibrational spectra of 2-[(2,4-dimethoxyphenyl) amino]-1,3-thiazolidin-4-one. J Mol Model. 2014; 20: 2366.
Omar YM, Abdel-Moty SG, Abdu-Allah HHM. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent. Bioorg Chem. 2020; 97: 103657.
Ottanà R, Maccari R, Barreca ML, Bruno G, Rotondo A, Rossi A, Chiricosta G, Di Paola R, Sautebin L, Cuzzocrea S, Vigorita MG. 5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents. Bioorg Med Chem. 2005; 13: 4243-52.
Ottanà R, Maccari R, Ciurleo R, Vigorita MG, Panico AM, Cardile V, Garufi F, Ronsisvalle S. Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures. Bioorg Med Chem. 2007; 15: 7618-25.
Rashid M, Husain A, Shaharyar M, Mishra R, Hussain A, Afzal O. Design and synthesis of pyrimidine molecules endowed with thiazolidin-4-one as new anticancer agents. Eur J Med Chem. 2014; 83: 630-45.
Saeed S, Rashid N, Jones PG, Ali M, Hussain R. Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential anti-microbial and anti-cancer agents. Eur J Med Chem. 2010; 45: 1323-31.
Şenkardeş S, Han Mİ, Kulabaş N, Abbak M, Çevik Ö, Küçükgüzel İ, Küçükgüzel ŞG. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anti-cancer agents and COX-2 inhibitors. Mol Divers. 2020; 24: 673-89.
Shafi S, Mahboob Alam M, Mulakayala N, Mulakayala C, Vanaja G, Kalle AM, Pallu R, Alam MS. Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: Their anti-inflammatory and anti-nociceptive activities. Eur J Med Chem. 2012; 49: 324–33.
Song EY, Kaur N, Park MY, Jin Y, Lee K, Kim G, Lee KY, Yang JS, Shin JH, Nam KY, No KT, Han G. Synthesis of amide and urea derivatives of benzothiazole as Raf-1 inhibitor. Eur J Med Chem. 2008; 43: 1519-24.
Stewart JJP. Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements. J Mol Model. 2007; 13: 1173-213.
Tatar E, Küçükgüzel İ, Küçükgüzel ŞG, Feyza Y, Clercq E De, Andrei G, Snoeck R, Pannecouque C, Fikrettin Ş, Bayrak ÖF. Synthesis, anti-tuberculosis and antiviral activity of vovel 2-isonicotinoylhydrazono-5-arylidene-4-thiazolidinones. Int J Drug Des Discov. 2010; 1: 19-32.
Türe A, Ergül Mustafa, Ergül Merve, Altun A, Küçükgüzel İ. Design, synthesis, and anti-cancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids. Mol Divers. 2021; 25: 1025-50.
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002; 45: 2615–23.
Vicini P, Geronikaki A, Anastasia K, Incerti M. FZ. Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones. Bioorg Med Chem. 2006; 14: 3859–64.
Vicini P, Geronikaki A, Incerti M, Zani F, Dearden J, Hewitt M. 2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: Synthesis and structure-activity relationship. Bioorg Med Chem. 2008; 16: 3714-24.
Wang JL, Limburg D, Graneto MJ, Springer J, Hamper JRB, Liao S, Pawlitz JL, Kurumbail RG, Maziasz T, Talley JJ, Kiefer JR, Carter J. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorg Med Chem Lett. 2010; 20: 7159-63.
Wang X, Sarris K, Kage K, Zhang D, Brown SP, Kolasa T, Surowy C, El Kouhen OF, Muchmore SW, Brioni JD, Stewart AO. Synthesis and evaluation of benzothiazole-based analo-gues as novel, potent, and selective fatty acid amide hydrolase inhibitors. J Med Chem. 2009; 52: 170-80.
Xu Y, Wang S, Hu Q, Gao S, Ma X, Zhang W, Shen Y, Chen F, Lai L, Pei J. CavityPlus: A web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction. Nucleic Acids Res. 2018; 46: W374-79.
Yuan Y, Pei J, Lai L. LigBuilder V3: A multi-target de novo drug design approach. Front Chem. 2020; 8: 1083-91.
Yuan Y, Pei J, Lai L. Binding site detection and druggability prediction of protein targets for structure-based drug design. Curr Pharm Des. 2013; 19: 2326-33.
Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I. Rate-limited steps of human oral absorption and QSAR studies. Pharm Res. 2002; 19: 1446-57.
Zheng CH, Zhou YJ, Zhu J, Ji HT, Chen J, Li YW, Sheng CQ, Lu JG, Jiang JH, Tang H, Song YL. Construction of a three-dimensional pharmacophore for Bcl-2 inhibitors by flexible docking and the multiple copy simultaneous search method. Bioorganic Med Chem. 2007; 15: 6407-17.
Zhou H, Wu S, Zhai S, Liu A, Sun Y, Li R, Zhang Y, Ekins S, Swaan PW, Fang B, Zhang B, Yan B. Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. J Med Chem. 2008; 51: 1242-51.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Necla Kulabas, Cansu Tamniku Guven, Merve Duracık, Ozlem Bingol Ozakpınar, İlkay Kucukguzel
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
